Formulary Matching for Households on Multiple Medications
For households on five or more active medications, the formulary is the plan. Two carriers with nearly identical premiums and networks can produce wildly divergent annual costs — sometimes a difference of $8,000 or more — based entirely on how each tiers your specific prescriptions. We map every active medication against every relevant formulary before recommending a plan. The analysis is documented.
What the Discipline Actually Involves
Complete Medication Inventory
We start with a full intake: every active prescription, the dosage, the prescribing physician, the preferred pharmacy, and any prior-authorization history. Specialty medications and biologic therapies receive particular attention.
Tier-by-Tier Mapping
For each plan on your short list, we map every medication against the carrier's current formulary — generic, preferred brand, non-preferred brand, specialty, and excluded. We surface tier differences that materially affect annual cost.
Prior-Authorization Risk Audit
Some plans require prior authorization for medications others cover without friction. We identify which of your prescriptions are likely to face PA requirements under each plan and what the renewal cadence looks like.
Tier-Shift Forecasting
Carrier formularies are updated annually — and sometimes mid-year. For plans you are seriously considering, we review recent formulary change history and flag medications likely to shift tier at renewal.
Specialty Drug Coverage Review
Specialty and biologic therapies — Humira, Enbrel, Stelara, Otezla, Tysabri, and similar — often have plan-specific coverage rules, preferred specialty pharmacies, and step-therapy requirements. We document those rules in writing before you enroll.
Pharmacy Network Verification
The right plan only works if your pharmacy is in network. We confirm preferred-pharmacy status for your specific location and flag any meaningful copay differential between preferred and standard network pharmacies.
When Formulary Matching Materially Changes the Recommendation
- Households on five or more active medications
- Patients on specialty or biologic therapies
- Anyone whose current medication recently shifted tier
- Medicare Part D enrollees re-evaluating during AEP
- Patients facing prior-authorization friction on a current plan
- Households where one family member's specialty drug dominates annual cost
Bring This to Your Intake
To make the most of your first conversation with a senior advisor, please bring a complete medication list — name, dosage, frequency, prescribing physician, and current pharmacy. Notes about prior-authorization history, recent tier changes, or coverage denials are particularly useful.
A Senior Advisor Is Available to Speak With You.
Share the broad outline of your situation. We respond personally within one business day to schedule a confidential intake.